Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer-Reference-Cited by-同舟云学术

Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer

Published:2021-01-25 Issue:7 Volume:27 Page:1855-1863
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Petroni Giulia^ORCID,Buqué Aitziber^ORCID,Yamazaki Takahiro,Bloy Norma,Liberto Maurizio Di,Chen-Kiang Selina,Formenti Silvia C.^ORCID,Galluzzi Lorenzo

Funder

Department of Radiation Oncology of Weill Cornell Medicine

NIHNCINCI

Leukemia and Lymphoma Society

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiosensitizing effects of CDK4/6 inhibitors in hormone receptor-positive and HER2-negative breast cancer mediated downregulation of DNA repair mechanism and NF-κB-signaling pathway;Translational Oncology;2024-11

2. Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pilot study;2024-09-01

3. Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting;The Prostate;2024-04-29

4. Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids;Journal of Visualized Experiments;2024-04-05

5. Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer;Frontiers in Oncology;2024-02-06